Besides, from the cellular compartment with the ELISPOT assay performed we are only assessing those PBMCs producing IFN-γ, but we are not assessing a wide range of immune cells that might be involved in controlling CMV infection. This evidence concerns the gene IFNG and cytomegalovirus infection.